Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
In the USA, the survey was conducted in 2003, and the age range is 16-34 (recalculated from original data).
In the European countries, most surveys (17 out of 19) were conducted between 2001 and 2004, and the standard age range is 15-34 (in some countries the lower end may be 16 or 18 years).
The European average prevalence rate was calculated as the average of the nationale prevalence rates weighted by national population of 15- to 34-year-olds (2001, taken from Eurostat).
Sources:
USA: SAMHSA, Office of Applied Studies, National Survey on Drug Use and Health, 2003 (www.samhsa.gov) and (http://oas.samhsa.gov/nhsda.htm#NHSDAinfo).
Europe: [Table GPS-11] in the 2005 EMCDDA statistical bulletin. Basend on Reitox national reports (2004).